| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |